Grantham, Mayo, Van Otterloo & Co (GMO)’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.02M Buy
14,545
+4,200
+41% +$314K ﹤0.01% 527
2026
Q2
$743K Hold
10,345
– – ﹤0.01% 544
2026
Q1
$1.22M Buy
10,345
+1,200
+13% +$148K ﹤0.01% 489
2025
Q4
$1.15M Buy
9,145
+1,335
+17% +$174K ﹤0.01% 497
2025
Q3
$1.14M Buy
7,810
+1,010
+15% +$153K ﹤0.01% 465
2025
Q2
$1.06M Buy
6,800
+2,500
+58% +$396K ﹤0.01% 473
2025
Q1
$708K Buy
+4,300
New +$715K ﹤0.01% 494

Other funds holding ZTS

Grantham, Mayo, Van Otterloo & Co (GMO)'s ZTS Position: Q3 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Zoetis (ZTS) stake by 41% in Q3 2026, buying an estimated $314K and bringing the position to 14,545 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #527.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ZTS in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.22M in Q1 2026. 1,164 funds tracked by Wall St. Rank hold ZTS as of Q3 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 14,545 shares of Zoetis worth $1.02M as of Q3 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 4,200 Zoetis shares in Q3 2026, an estimated $314K.
  • Zoetis made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q3 2026, its #527 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Zoetis in Q1 2025 and has held it in 7 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Zoetis position peaked at $1.22M in Q1 2026.
  • 1,164 funds tracked by Wall St. Rank held Zoetis as of Q3 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2026, filed 13 Nov 2026.